228 related articles for article (PubMed ID: 29346163)
1. The Hippo Signaling Pathway in the Regulation of Skeletal Muscle Mass and Function.
Watt KI; Goodman CA; Hornberger TA; Gregorevic P
Exerc Sport Sci Rev; 2018 Apr; 46(2):92-96. PubMed ID: 29346163
[TBL] [Abstract][Full Text] [Related]
2. Cysteine S-Glutathionylation Promotes Stability and Activation of the Hippo Downstream Effector Transcriptional Co-activator with PDZ-binding Motif (TAZ).
Gandhirajan RK; Jain M; Walla B; Johnsen M; Bartram MP; Huynh Anh M; Rinschen MM; Benzing T; Schermer B
J Biol Chem; 2016 May; 291(22):11596-607. PubMed ID: 27048650
[TBL] [Abstract][Full Text] [Related]
3. Regulation of the Hippo Pathway Transcription Factor TEAD.
Lin KC; Park HW; Guan KL
Trends Biochem Sci; 2017 Nov; 42(11):862-872. PubMed ID: 28964625
[TBL] [Abstract][Full Text] [Related]
4. [Role of Hippo-YAP/TAZ signaling pathway in mechanotransduction.].
Ishihara E; Nishina H
Clin Calcium; 2016; 26(12):1751-1756. PubMed ID: 27885187
[TBL] [Abstract][Full Text] [Related]
5. Hippo Component TAZ Functions as a Co-repressor and Negatively Regulates ΔNp63 Transcription through TEA Domain (TEAD) Transcription Factor.
Valencia-Sama I; Zhao Y; Lai D; Janse van Rensburg HJ; Hao Y; Yang X
J Biol Chem; 2015 Jul; 290(27):16906-17. PubMed ID: 25995450
[TBL] [Abstract][Full Text] [Related]
6. Autopalmitoylation of TEAD proteins regulates transcriptional output of the Hippo pathway.
Chan P; Han X; Zheng B; DeRan M; Yu J; Jarugumilli GK; Deng H; Pan D; Luo X; Wu X
Nat Chem Biol; 2016 Apr; 12(4):282-9. PubMed ID: 26900866
[TBL] [Abstract][Full Text] [Related]
7. The Hippo pathway effector TAZ induces TEAD-dependent liver inflammation and tumors.
Hagenbeek TJ; Webster JD; Kljavin NM; Chang MT; Pham T; Lee HJ; Klijn C; Cai AG; Totpal K; Ravishankar B; Yang N; Lee DH; Walsh KB; Hatzivassiliou G; de la Cruz CC; Gould SE; Wu X; Lee WP; Yang S; Zhang Z; Gu Q; Ji Q; Jackson EL; Lim DS; Dey A
Sci Signal; 2018 Sep; 11(547):. PubMed ID: 30206136
[TBL] [Abstract][Full Text] [Related]
8. Hippo-YAP/TAZ signaling in angiogenesis.
Park JA; Kwon YG
BMB Rep; 2018 Mar; 51(3):157-162. PubMed ID: 29366443
[TBL] [Abstract][Full Text] [Related]
9. YAP and WWTR1: New targets for skin cancer treatment.
Andl T; Zhou L; Yang K; Kadekaro AL; Zhang Y
Cancer Lett; 2017 Jun; 396():30-41. PubMed ID: 28279717
[TBL] [Abstract][Full Text] [Related]
10. Molecular mechanisms of the mammalian Hippo signaling pathway.
Ji XY; Zhong G; Zhao B
Yi Chuan; 2017 Jul; 39(7):546-567. PubMed ID: 28757470
[TBL] [Abstract][Full Text] [Related]
11. The Hippo pathway effector YAP is a critical regulator of skeletal muscle fibre size.
Watt KI; Turner BJ; Hagg A; Zhang X; Davey JR; Qian H; Beyer C; Winbanks CE; Harvey KF; Gregorevic P
Nat Commun; 2015 Jan; 6():6048. PubMed ID: 25581281
[TBL] [Abstract][Full Text] [Related]
12. The Hippo signal transduction network for exercise physiologists.
Gabriel BM; Hamilton DL; Tremblay AM; Wackerhage H
J Appl Physiol (1985); 2016 May; 120(10):1105-17. PubMed ID: 26940657
[TBL] [Abstract][Full Text] [Related]
13. Hippo Pathway: An Emerging Regulator of Craniofacial and Dental Development.
Wang J; Martin JF
J Dent Res; 2017 Oct; 96(11):1229-1237. PubMed ID: 28700256
[TBL] [Abstract][Full Text] [Related]
14. Yes-Associated Protein and PDZ Binding Motif: A Critical Signaling Pathway in the Control of Human Pluripotent Stem Cells Self-Renewal and Differentiation.
Shi J; Farzaneh M; Khoshnam SE
Cell Reprogram; 2020 Apr; 22(2):55-61. PubMed ID: 32125897
[TBL] [Abstract][Full Text] [Related]
15. Hippo pathway - brief overview of its relevance in cancer.
Zygulska AL; Krzemieniecki K; Pierzchalski P
J Physiol Pharmacol; 2017 Jun; 68(3):311-335. PubMed ID: 28820389
[TBL] [Abstract][Full Text] [Related]
16. Hippo Pathway Regulation by Tyrosine Kinases.
Reuven N; Shanzer M; Shaul Y
Methods Mol Biol; 2019; 1893():215-236. PubMed ID: 30565137
[TBL] [Abstract][Full Text] [Related]
17. VGLL3 operates via TEAD1, TEAD3 and TEAD4 to influence myogenesis in skeletal muscle.
Figeac N; Mohamed AD; Sun C; Schönfelder M; Matallanas D; Garcia-Munoz A; Missiaglia E; Collie-Duguid E; De Mello V; Pobbati AV; Pruller J; Jaka O; Harridge SDR; Hong W; Shipley J; Vargesson N; Zammit PS; Wackerhage H
J Cell Sci; 2019 Jul; 132(13):. PubMed ID: 31138678
[TBL] [Abstract][Full Text] [Related]
18. DUB3 Deubiquitylating Enzymes Regulate Hippo Pathway Activity by Regulating the Stability of ITCH, LATS and AMOT Proteins.
Nguyen HT; Kugler JM; Cohen SM
PLoS One; 2017; 12(1):e0169587. PubMed ID: 28061504
[TBL] [Abstract][Full Text] [Related]
19. KIBRA exhibits MST-independent functional regulation of the Hippo signaling pathway in mammals.
Moleirinho S; Chang N; Sims AH; Tilston-Lünel AM; Angus L; Steele A; Boswell V; Barnett SC; Ormandy C; Faratian D; Gunn-Moore FJ; Reynolds PA
Oncogene; 2013 Apr; 32(14):1821-30. PubMed ID: 22614006
[TBL] [Abstract][Full Text] [Related]
20. The Hippo-YAP pathway: new connections between regulation of organ size and cancer.
Zhao B; Lei QY; Guan KL
Curr Opin Cell Biol; 2008 Dec; 20(6):638-46. PubMed ID: 18955139
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
